Description

PT-141 10mg + Water – Driada Medical

• Active Ingredient: PT-141 (Bremelanotide), a cyclic heptapeptide and an analog of the alpha-melanocyte-stimulating hormone (α-MSH).
• Mechanism of Action: It acts as a melanocortin receptor agonist, primarily targeting the MC3R and MC4R receptors in the brain’s hypothalamus to modulate pathways involved in sexual response and motivation. This leads to the release of neurotransmitters like dopamine and oxytocin, which enhance desire and arousal.
• Intended Use: It is used to address sexual desire disorders, particularly hypoactive sexual desire disorder (HSDD) in premenopausal women (for which an injectable form is FDA-approved as Vyleesi). It is also used off-label to treat erectile dysfunction in men, especially those who do not respond to PDE5 inhibitors like Viagra or Cialis.
• Administration: It is typically administered via subcutaneous injection after being reconstituted with bacteriostatic water.
• Dosage: A typical dose for injection is around 1.75 mg to 2 mg, administered at least 45 minutes before sexual activity. It is recommended not to exceed one dose per 24 hours or eight doses per month.